The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AGA Management of IBD is complex and challenging. This session will have IBD experts discuss evidence-based approaches to four common and challenging scenarios in IBD: choosing among available biologic and small molecule therapies based on patient profiles, proper use of therapeutic drug monitoring, management of fistulizing Crohn's, and diagnosis and management of refractory pouch disorders.
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…